跳到正文
原文
NEJM· @NEJM · X·· 26 天前AI 评分30
AI 导读

急性冠脉综合征后,在抗血小板治疗基础上加用milvexian能否降低心血管死亡、心肌梗死或缺血性卒中?一项新Quick Take视频总结了研究结果。https://nej.md/4BjwM56

正文

Does adding milvexian to antiplatelet therapy after acute coronary syndrome reduce cardiovascular death, myocardial infarction, or ischemic stroke? Research findings are summarized in a new Quick Take video. https://nej.md/4BjwM56

来源:NEJM · x.com